One Hundred-Fifth Meeting
Wednesday and Thursday, September 24-25, 2008
Building 31, C Wing, Conference Room 6
Day-of-the-Meeting Contact Phone: 301-402-8578
WEDNESDAY, SEPTEMBER 24
3:00 to 5:00 p.m. – This portion of the meeting is closed to the Public
This portion of the meeting is closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S. Code and Section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2).
Review of Applications: Dr. Robin Barr
THURSDAY, SEPTEMBER 25
8:00 to 8:45 a.m. - This portion of the meeting is open to the public
-
Call to Order
Dr. Richard Hodes- Director’s Status Report
-
Future Meeting Dates:
Jan 27-28, 2009 (Tue-Wed)
May 19-20, 2009 (Tue-Wed)
Sept 22-23, 2009 (Tue-Wed) - Consideration of Minutes of Last Meeting
8:45 to 9:15 a.m.
-
Report: Task Force on Minority Aging Research
Dr. Terry Mills
9:15 to 9:45 a.m.
-
Report: Working Group on Program
Dr. John Morris- Action: Advisory Meetings
9:45 to 10:00 a.m.
COFFEE BREAK
10:00 to 10:15 a.m.
-
Comments from Retiring Members
Drs. Greengard, Mills, Siu, and Tinetti
10:15 to 10:20 a.m.
-
Report: Council of Councils
Ms. Orien Reed
10:20 to 10:30 a.m.
-
Initial Report: Division of Behavioral and Social Research Review
Dr. John Morris
10:30 to 11:05 a.m.
-
Report: Division of Neuroscience Review
Dr. John Morris
11:05 to 11:50 a.m.
-
Presentation: Collaborations Between CTSA Programs and NIH Institutes
Dr. Eric Orwoll
Oregon Health and Science University
11:50 to 12:05 p.m.
BREAK
12:05 to 2:05 p.m.
-
Division Highlights (Working Lunch): Division Directors, NIA and invited presenters
(12:05-12:35) Central Regulation of Bone Mass
Dr. Gerard Karsenty
Columbia University
(12:35-1:05) The Emerging Role of Signal Transduction in Alzheimer's Disease
Dr. Dale Bredesen
Buck Institute for Age Research
(1:05-1:35) Cognitive Impairment and Dementia in the United States: Initial Findings from the HRS and ADAMS
Dr. Kenneth Langa
University of Michigan
(1:35-2:05) Selective Serotonin Reuptake Inhibitors (SSRIs) and Bone Health: Evidence from the Study of Osteoporotic Fractures
Dr. Susan Diem,
University of Minnesota
2:05 to 2:30 p.m.--This portion of the meeting is closed to the Public
This portion of the meeting is being closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S. Code and Section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2).
- Review of the Scientific Director : Dr. Richard Hodes
2:30 p.m.
- Adjournment
